Gf Fund Management Co. Ltd. Erasca, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.51 Trillion
- Q3 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Erasca, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 6,033 shares of ERAS stock, worth $15,565. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,033
Previous 7,240
16.67%
Holding current value
$15,565
Previous $9.2 Million
43.03%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ERAS
# of Institutions
155Shares Held
213MCall Options Held
281KPut Options Held
32K-
Frazier Life Sciences Management, L.P. Menlo Park, CA22.7MShares$58.6 Million2.1% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD20.2MShares$52.2 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY17.9MShares$46.1 Million5.91% of portfolio
-
Logos Global Management LP San Francisco, CA15.2MShares$39.1 Million3.82% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.5MShares$37.4 Million0.95% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $315M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...